Christopher Lepsy

611 total citations
18 papers, 417 citations indexed

About

Christopher Lepsy is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher Lepsy has authored 18 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher Lepsy's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Biosimilars and Bioanalytical Methods (5 papers) and CAR-T cell therapy research (4 papers). Christopher Lepsy is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Biosimilars and Bioanalytical Methods (5 papers) and CAR-T cell therapy research (4 papers). Christopher Lepsy collaborates with scholars based in United States, Poland and Italy. Christopher Lepsy's co-authors include Chengjie Ji, Nalini Sadagopan, Wenlin Li, Vitaly Ablamunits, Yizhong Zhang, Rouba Kozak, Scott Fountain, Ayman El‐Kattan, Charles J. Stankovic and Eric Gifford and has published in prestigious journals such as Gastroenterology, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Christopher Lepsy

18 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Lepsy United States 11 166 89 76 64 58 18 417
Steven Hansel United States 14 200 1.2× 53 0.6× 41 0.5× 166 2.6× 25 0.4× 29 683
Anne Cooper United Kingdom 13 155 0.9× 81 0.9× 23 0.3× 211 3.3× 44 0.8× 20 724
Keun Na South Korea 14 356 2.1× 67 0.8× 126 1.7× 88 1.4× 13 0.2× 25 624
Piet Swart Switzerland 12 221 1.3× 31 0.3× 30 0.4× 53 0.8× 23 0.4× 17 421
Jyotika Varshney United States 15 207 1.2× 39 0.4× 20 0.3× 54 0.8× 56 1.0× 25 493
Martha Lucía Serrano Colombia 10 278 1.7× 58 0.7× 17 0.2× 75 1.2× 53 0.9× 47 546
Stefan Müllner Germany 15 340 2.0× 160 1.8× 76 1.0× 144 2.3× 26 0.4× 30 650
Anke Schnabel Germany 8 209 1.3× 71 0.8× 81 1.1× 49 0.8× 79 1.4× 8 416
Patricia Zane United States 11 104 0.6× 185 2.1× 48 0.6× 39 0.6× 12 0.2× 15 474
Karishma Patel Australia 10 250 1.5× 19 0.2× 26 0.3× 143 2.2× 22 0.4× 24 512

Countries citing papers authored by Christopher Lepsy

Since Specialization
Citations

This map shows the geographic impact of Christopher Lepsy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lepsy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lepsy more than expected).

Fields of papers citing papers by Christopher Lepsy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Lepsy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lepsy. The network helps show where Christopher Lepsy may publish in the future.

Co-authorship network of co-authors of Christopher Lepsy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Lepsy. A scholar is included among the top collaborators of Christopher Lepsy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Lepsy. Christopher Lepsy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tourdot, Sophie, Donna S. Cox, Chunhua Cai, et al.. (2025). Antidrug antibodies to adalimumab do not associate with immunologically related adverse events. Frontiers in Immunology. 15. 1457993–1457993. 3 indexed citations
2.
3.
Joyce, Alison, et al.. (2022). Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response Maturation. The AAPS Journal. 24(6). 114–114. 9 indexed citations
4.
Ablamunits, Vitaly & Christopher Lepsy. (2022). Blocking TNF signaling may save lives in COVID-19 infection. Molecular Biology Reports. 49(3). 2303–2309. 25 indexed citations
5.
Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2021). Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study. Clinical Gastroenterology and Hepatology. 19(11). 2324–2332.e6. 60 indexed citations
6.
7.
Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2020). 1027 SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A ANTIBODY PF-06480605 IN TREATMENT OF ULCERATIVE COLITIS: THE OPEN-LABEL, MULTICENTER, PHASE 2A TUSCANY STUDY. Gastroenterology. 158(6). S–206. 1 indexed citations
8.
Gorovits, Boris, et al.. (2019). Anti-drug Antibody Assay Conditions Significantly Impact Assay Screen and Confirmatory Cut-Points. The AAPS Journal. 21(4). 71–71. 4 indexed citations
9.
Banfield, Christopher, Dan Rudin, Indranil Bhattacharya, et al.. (2019). First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects. British Journal of Clinical Pharmacology. 86(4). 812–824. 21 indexed citations
10.
Wang, Mengmeng, Amanda Kussrow, Mireia Fernández Ocaña, et al.. (2016). Physiologically relevant binding affinity quantification of monoclonal antibody PF‐00547659 to mucosal addressin cell adhesion molecule for in vitro in vivo correlation. British Journal of Pharmacology. 174(1). 70–81. 12 indexed citations
11.
12.
Chang, Cheng, David B. Duignan, Pil H. Lee, et al.. (2009). The Development and Validation of a Computational Model to Predict Rat Liver Microsomal Clearance. Journal of Pharmaceutical Sciences. 98(8). 2857–2867. 16 indexed citations
13.
14.
15.
Li, Na, Olga V. Nemirovskiy, Yiqun Zhang, et al.. (2008). Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry. Analytical Biochemistry. 380(2). 211–222. 56 indexed citations
16.
Ji, Chengjie, Wenlin Li, Ayman El‐Kattan, et al.. (2008). Diethylation Labeling Combined with UPLC/MS/MS for Simultaneous Determination of a Panel of Monoamine Neurotransmitters in Rat Prefrontal Cortex Microdialysates. Analytical Chemistry. 80(23). 9195–9203. 77 indexed citations
17.
Stoner, Chad, Eric Gifford, Charles J. Stankovic, et al.. (2004). Implementation of an ADME enabling selection and visualization tool for drug discovery. Journal of Pharmaceutical Sciences. 93(5). 1131–1141. 30 indexed citations
18.
Lepsy, Christopher, Robert Guttendorf, Alan R. Kugler, & David E. Smith. (2003). Effects of Organic Anion, Organic Cation, and Dipeptide Transport Inhibitors on Cefdinir in the Isolated Perfused Rat Kidney. Antimicrobial Agents and Chemotherapy. 47(2). 689–696. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Hansel Breakdown of academic impact, for papers by Anne Cooper Breakdown of academic impact, for papers by Keun Na Breakdown of academic impact, for papers by Piet Swart Breakdown of academic impact, for papers by Jyotika Varshney Breakdown of academic impact, for papers by Martha Lucía Serrano Breakdown of academic impact, for papers by Stefan Müllner Breakdown of academic impact, for papers by Anke Schnabel Breakdown of academic impact, for papers by Patricia Zane Breakdown of academic impact, for papers by Karishma Patel
Rankless by CCL
2026